|
| Status |
Public on Jun 23, 2007 |
| Title |
C_094_065_01_PDS275_D B |
| Sample type |
genomic |
| |
|
| Source name |
HELA ATCC; Control genomic dna (untreated)
|
| Organism |
Homo sapiens |
| Characteristics |
HELA ATCC
|
| Treatment protocol |
Cells were lysed and Intact nuclei were isolated using NP40. Nuclei were lysed using SDS and treated overnight with Proteinase K
|
| Growth protocol |
RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g-L sodium bicarbonate. 4.5 g-L glucose. 10 mM HEPES and 1.0 mM sodium pyruvate and supplemented with 0.5 mg-ml G418 and 10percent fetal bovine serum
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Samples were extracted/cleaned using Qiagen Midi Preps according to manufacturer
|
| Label |
biotin
|
| Label protocol |
Fragments were cleaned using Qiagen PCR columns. Samples were amplified using the Sigma WGA amplification kit. Cleaned and fragmented to an avg size of 75 bp using DNaseI and labeled with Biotin 16-ddUTP and Terminal Transferase. (See Affymetrix Chip Chip protocol)
|
| |
|
| Hybridization protocol |
Labeled samples were hybridized for 16 hr at 45C on Affymetrix whole Genome Tiling Arrays. Arrays were washed and post stained using the Affymetrix 450 Fluidics Station.
|
| Scan protocol |
Arrays were scanned using an Affymetrix GeneChip Scanner 3000.
|
| Description |
Control genomic dna (untreated)
|
| Data processing |
Cel files were generated using Affymetrix's GCOS software and Analyzed using the Affymetrix TAS analysis software.
|
| |
|
| Submission date |
Mar 01, 2007 |
| Last update date |
Jun 23, 2007 |
| Contact name |
John A Stamatoyannopoulos |
| E-mail(s) |
jstam@altius.org
|
| Organization name |
Altius Institute / University of Washington
|
| Department |
Genome Sciences
|
| Lab |
Stamatoyannopoulos
|
| Street address |
2211 Elliott Avenue, 6th Floor
|
| City |
SEATTLE |
| State/province |
WA |
| ZIP/Postal code |
98121 |
| Country |
USA |
| |
|
| Platform ID |
GPL4911 |
| Series (3) |
| GSE7168 |
DNaseI sensitivity/hypersensitivity Part I |
| GSE8222 |
DNaseI sensitivity/hypersensitivity |
| GSE11298 |
Tissue/Cell DNaseI sensitivity/hypersensitivity screening II |
|
